Cursos de otras instituciones
ISTH · Emerging Nonfactor Approaches for Patients with HEMOPHILIA Enhancing and rebuilding therapies
Actividad formativa
Through this education, you will have improved abilities to:
- Describe how novel agents including those targeting antithrombin, FVIIIa, and tissue factor pathway inhibitor (TFPI) are being developed for patients with hemophilia to enhance and rebalance the hemostatic system
- Summarize currente clinical studies of thes novel therapies for hemophilia
- Outline potential concerns regarding these novel therapies